TY - JOUR
T1 - Technical report
T2 - Exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans
AU - Kaas, Bonnie
AU - Vaidya, Avinash R.
AU - Leatherman, Amanda
AU - Schleidt, Stephanie
AU - Kohn, Rebecca Eustance
N1 - Funding Information:
Acknowledgments We thank David Sattelle for the inspiration for these laboratory experiments. Students in the Molecular Neurobiology course at Ursinus College all participated in planning and executing experiments and in interpreting experimental results. These students included, Brigid Bleaken, Lauren Brady, Ashley Feigenbutz, Laura Gurenlian, Danielle Indelicato, Krithika Krishnarao, Cierra Lewis, Elizabeth Marion, Lauren Myers, Bindu Pirlamarla, Stephanie Rogman, Noelle Romero, Larissa Stuckey, Nicholas Turner, Douglas Yodice, and Jonathan Zhou. We thank Kenton Woodard for making stock solutions and organizing laboratory materials. We thank Roger Coleman for his assistance with statistical analysis. C. elegans strains were provided by the C. elegans Genetics Center. This material is based upon work supported by the National Science Foundation under Grant No. 0544031 to REK.
PY - 2010/11
Y1 - 2010/11
N2 - Mutations affecting acetylcholine receptors have been causally linked to the development of congenital myasthenic syndromes (CMS) in humans resulting from neuromuscular transmission defects. In an undergraduate Molecular Neurobiology course, the molecular basis of CMS was explored through study of a Caenorhabditis elegans model of the disease. The nicotinic acetylcholine receptor (nAChR), located on the postsynaptic muscle cell membrane, contains a pentameric ring structure comprised of five homologous subunits. In the nematode C. elegans, unc-63 encodes an a subunit of nAChR. UNC-63 is required for the function of nAChR at the neuromuscular junction. Mutations in unc-63 result in defects in locomotion and egg-laying and may be used as models for CMS. Here, we describe the responses of four unc-63 mutants to the cholinesterase inhibitor pyridostigmine bromide (range 0.9-15.6 mM in this study), a treatment for CMS that mitigates deficiencies in cholinergic transmission by elevating synaptic ACh levels. Our results show that 15.6 mM pyridostigmine bromide enhanced mobility in two alleles, depressed mobility in one allele and in N2, while having no effect on the fourth allele. This indicates that while pyridostigmine bromide may be effective at ameliorating symptoms of CMS in certain cases, it may not be a suitable treatment for all individuals due to the diverse etiology of this disease. Students in the Molecular Neurobiology course enhanced their experience in scientific research by conducting an experiment designed to increase understanding of genetic defects of neurological function.
AB - Mutations affecting acetylcholine receptors have been causally linked to the development of congenital myasthenic syndromes (CMS) in humans resulting from neuromuscular transmission defects. In an undergraduate Molecular Neurobiology course, the molecular basis of CMS was explored through study of a Caenorhabditis elegans model of the disease. The nicotinic acetylcholine receptor (nAChR), located on the postsynaptic muscle cell membrane, contains a pentameric ring structure comprised of five homologous subunits. In the nematode C. elegans, unc-63 encodes an a subunit of nAChR. UNC-63 is required for the function of nAChR at the neuromuscular junction. Mutations in unc-63 result in defects in locomotion and egg-laying and may be used as models for CMS. Here, we describe the responses of four unc-63 mutants to the cholinesterase inhibitor pyridostigmine bromide (range 0.9-15.6 mM in this study), a treatment for CMS that mitigates deficiencies in cholinergic transmission by elevating synaptic ACh levels. Our results show that 15.6 mM pyridostigmine bromide enhanced mobility in two alleles, depressed mobility in one allele and in N2, while having no effect on the fourth allele. This indicates that while pyridostigmine bromide may be effective at ameliorating symptoms of CMS in certain cases, it may not be a suitable treatment for all individuals due to the diverse etiology of this disease. Students in the Molecular Neurobiology course enhanced their experience in scientific research by conducting an experiment designed to increase understanding of genetic defects of neurological function.
KW - Acetylcholinesterase
KW - Caenorhabditis elegans
KW - Congenital myasthenic syndromes
KW - Nicotinic acetylcholine receptor
KW - Undergraduate
UR - http://www.scopus.com/inward/record.url?scp=78951493034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78951493034&partnerID=8YFLogxK
U2 - 10.1007/s10158-010-0101-2
DO - 10.1007/s10158-010-0101-2
M3 - Article
C2 - 20431904
AN - SCOPUS:78951493034
SN - 1354-2516
VL - 10
SP - 17
EP - 23
JO - Invertebrate Neuroscience
JF - Invertebrate Neuroscience
IS - 1
ER -